Fundraising Fox
Tulavi Therapeutics
Mountain View, US · Founded 2018 · Delaware corporation · 50 employees on LinkedIn · 2 known investors
Find your way into Tulavi Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
316 people can intro you to Josh
Ask Adrian Mendes to introduce you to Josh Vose
You →Adrian · together at Perimeter Medical Imaging →Josh
Sign up to find every way you can get introduced to Tulavi Therapeutics
- Your email: who you already know at Tulavi Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tulavi Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
Founders & leadership
Tulavi Therapeutics was founded in 2018 by Farhad Khosravi and Fred Khosravi.
FK
Farhad KhosraviCo-founder
JV
Josh VoseChief Executive OfficerJosh Vose is a physician and engineer who serves as CEO of Tulavi Therapeutics, which develops medical devices for peripheral nerve surgery. He has prior experience scaling startups and managing business operations.
CB
Corinne BrightNamed on SEC filing
Board
HC
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 4 rounds · 2018–2021
▶$1MraisedDec 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Greg CasciaroDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$7.5MraisedMar 2021 · 3 investors · BiotechnologyRule 506(b)
▶$7.5MraisedMar 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Corinne BrightExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $7.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedMay 2020 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Amar SawneyDirector
- Corinne BrightExecutive Officer, Director
- Henry ChenDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedDec 2018 · 3 investors · Other Health CareRule 506(c)
▶$3MraisedDec 2018 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Henry ChenDirector
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $160K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Noctrix HealthNoctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes. The company targets patients living with chronic conditions such as restless legs syndrome, offering prescription-grade therapy through medical devices.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies working in the same space as Tulavi Therapeutics.
Frequently asked questions
- What does Tulavi Therapeutics do?
- Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
- Who founded Tulavi Therapeutics?
- Tulavi Therapeutics was founded by Farhad Khosravi, Fred Khosravi in 2018.
- Who are Tulavi Therapeutics's investors?
- Tulavi Therapeutics's investors include Ascension Ventures, Delos Capital.
- How much funding has Tulavi Therapeutics raised?
- Tulavi Therapeutics has disclosed $14.5M raised across 4 rounds.
- Where is Tulavi Therapeutics headquartered?
- Tulavi Therapeutics is headquartered in Mountain View, US.